The epidemiology of cardiovascular disease in type 2 diabetes mellitus: How sweet it is . . . or is it?

Lancet

Volumn 350, Issue SUPPL.1, 1997, Pages 4-9

  Nathan, David M ^a,b   Meigs, James ^a   Singer, Daniel E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0030790435     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90021-0     Document Type: Article

References (58)

1. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36: 523-34.
2. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-85.
3. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Harris M, ed. Diabetes in America, 2nd ed. Bethesda: National Institutes of Health, 1995: 233-55.
4. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124: 136-45.
5. Wingard DL, Barrett-Connors E. Heart disease and diabetes. In: Harris M, ed. Diabetes in America, 2nd ed. Bethesda: National Institutes of Health, 1995: 429-56.
6. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 123-31.
7. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 463-524.
8. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 1985; 28: 615-40.
9. Howard BV, Lee ET, Fabsitz RR, et al. Diabetes and coronary heart disease in American Indians: the Strong Heart Study. Diabetes 1996; 45 (suppl 3): S6-S13.
10. Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction: interaction with other risk factors. Diabetes 1989; 38: 350-57.
11. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296-306.
12. Smith DA. Comparative approaches to risk reduction of coronary heart disease in Tecumseh non-insulin-dependent diabetic population. Diabetes Care 1986; 9: 601-08.
13. Kuusisto J, Mykkanen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-67.
14. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-47.
15. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-19.
16. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. JAMA 1990; 263: 2893-98.
17. Wingard DL, Barrett-Connors E, Criqui MH, Suarez L. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 1983; 117: 19-26.
18. Ford ES, DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Am J Epidemiol 1991; 133: 1220-30.
19. Wilson PWF, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly: the Framingham Study. Am J Med 1986; 80 (suppl 5A): 3-9.
20. Siegel RD, Cupples A, Schaefer EJ, Wilson PWF. Lipoproteines, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 1996; 45: 1267-72.
21. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.
22. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (The Framingham Heart Study). Am J Cardiol 1987; 59: 916-46.
23. Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycaemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123: 504-16.
24. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988; 128: 389-401.
25. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 1991; 265: 627-31.
26. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
27. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
29. Knatterud GL, Klimt CR, Levin ME, Jacobsen ME, Goldner MG. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. JAMA 1978; 240: 37-42.
30. Abraira C, Colwell J, Nutall F, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Arch Intern Med 1997; 157: 181-88.
31. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35: 1332-39.
32. West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-69.
33. Ito H, Harano Y, Suzuki M, et al. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Diabetes 1996; 45 (suppl 3): S19-S23.
34. Meigs JB, Singer DE, Sullivan L, et al. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus: the NIDDM Patient Outcomes Research Team. Am J Med 1997; 102: 38-47.
35. Haffner SM, Mitchell BD, Stern MP, Hazuda HP. Macrovascular complications in Mexican Americans with type II diabetes. Diabetes Care 1991; 14 (suppl 3): 665-71.
36. Wingard DL, Barrett-Connor E. Family history of diabetes and cardiovascular disease risk factors and mortality among euglycemic, borderline hyperglycemic, and diabetic adults. Am J Epidemiol 1987; 125: 948-58.
37. Gall MA, Rossing P, Skott P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy, and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
38. Laakso M, Lehto S, Penttila I, Pyörälä K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-30.
39. Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43.
40. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulm-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-84.
41. Fu CC, Chang CJ, Tseng CH, et al. Development of macrovascular diseases in NIDDM patients in northern Taiwan. Diabetes Care 1993; 16:137-43.
42. MOSS SE, Klein R, Klein BEK, Meuer SM, The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-79.
43. Singer DE, Nathan DM, Anderson KM, et al. Association of HbA with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-08.
44. Park S, Barrett-Connors E, Wingard DL, et al. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. Diabetes Care 1997; 19: 450-56.
45. Coutinino M, Wang Y, Gerstein HC,Yusuf S. Continuous relationship of glucose with cardiovacular events in non-diabetic subjects: a metaregression analysis of 18 studies in 88,000 individuals. Circulation 1996; 94 (suppl 1): I-214.
46. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. Lancet 1980; i: 1373-76.
47. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
48. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis 1984; 37: 773-79.
49. Meigs JB, Nathan DM, Singer DE, et al. Metabolic abnormalities associated with glucose intolerance extend across the spectrum of prevalent glucose tolerance in 3297 Framingham offspring study subjects. Diabetes 1995; 44 (suppl 1): 5A.
50. Stout R. Insulin and atheroma. Diabetes Care 1990; 13: 631-54.
51. Eschwege E, Richard JL,Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose, and plasma insulin levels. Horm Metab Res Suppl 1985; 15: 41-45.
52. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-41.
53. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-60.
54. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-92.
55. Pyörälä K, Pedersen TR, Kjekshus J. The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary artery disease. Diabetes 1995; 44 (suppl 1): 35A.
56. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-09.
57. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes 1974; 23: 105-11.
58. Wilson PW, Kannel WB, Anderson KM. Lipids, glucose intolerance and vascular disease: the Framingham study. Monogr Atherosclerosis 1985; 13: 1-11.